Integrated control of cancer stemness by σ1 receptor in advanced prostate cancer.

Saved in:
Bibliographic Details
Title: Integrated control of cancer stemness by σ1 receptor in advanced prostate cancer.
Authors: Civenni G; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Sandrini G; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.; Bioinformatics Core Unit, Institute of Oncology Research (IOR) and Swiss Institute of Bioinformatics, Bellinzona, Switzerland., Merulla J; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Musumeci C; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Federici E; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Vallegra A; Mario Negri Institute for Pharmacological Research, Milano, Italy., Kokanovic A; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Mosole S; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Shinde D; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Sorrenti E; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Paganoni AJJ; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Marchetti M; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Valzelli R; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Albino D; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Pecoraro M; Institute for Research in Biomedicine (IRB), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Rinaldi A; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Bolis M; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.; Bioinformatics Core Unit, Institute of Oncology Research (IOR) and Swiss Institute of Bioinformatics, Bellinzona, Switzerland.; Mario Negri Institute for Pharmacological Research, Milano, Italy., Geiger R; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.; Institute for Research in Biomedicine (IRB), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Winge T; Institut für Pharmazeutische und Medizinische Chemie, Westfälische Wilhelms-Universität Münster, Münster, Germany., Holtschulte C; Institut für Pharmazeutische und Medizinische Chemie, Westfälische Wilhelms-Universität Münster, Münster, Germany., Laurini E; Molecular Biology and Nanotechnology Laboratory (MolBNL@UniTS), DEA, University of Trieste, Trieste, Italy., Pricl S; Molecular Biology and Nanotechnology Laboratory (MolBNL@UniTS), DEA, University of Trieste, Trieste, Italy., Carbone GM; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland., Wünsch B; Institut für Pharmazeutische und Medizinische Chemie, Westfälische Wilhelms-Universität Münster, Münster, Germany., Catapano CV; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland. carlo.catapano@ior.usi.ch.
Source: Oncogene [Oncogene] 2025 Nov; Vol. 44 (42), pp. 4032-4046. Date of Electronic Publication: 2025 Sep 02.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40897798
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Integrated control of cancer stemness by σ<subscript>1</subscript> receptor in advanced prostate cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Civenni+G%22">Civenni G</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sandrini+G%22">Sandrini G</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.; Bioinformatics Core Unit, Institute of Oncology Research (IOR) and Swiss Institute of Bioinformatics, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Merulla+J%22">Merulla J</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Musumeci+C%22">Musumeci C</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Federici+E%22">Federici E</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Vallegra+A%22">Vallegra A</searchLink>; Mario Negri Institute for Pharmacological Research, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Kokanovic+A%22">Kokanovic A</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mosole+S%22">Mosole S</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Shinde+D%22">Shinde D</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sorrenti+E%22">Sorrenti E</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Paganoni+AJJ%22">Paganoni AJJ</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Marchetti+M%22">Marchetti M</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Valzelli+R%22">Valzelli R</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Albino+D%22">Albino D</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pecoraro+M%22">Pecoraro M</searchLink>; Institute for Research in Biomedicine (IRB), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Rinaldi+A%22">Rinaldi A</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bolis+M%22">Bolis M</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.; Bioinformatics Core Unit, Institute of Oncology Research (IOR) and Swiss Institute of Bioinformatics, Bellinzona, Switzerland.; Mario Negri Institute for Pharmacological Research, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Geiger+R%22">Geiger R</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.; Institute for Research in Biomedicine (IRB), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Winge+T%22">Winge T</searchLink>; Institut für Pharmazeutische und Medizinische Chemie, Westfälische Wilhelms-Universität Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Holtschulte+C%22">Holtschulte C</searchLink>; Institut für Pharmazeutische und Medizinische Chemie, Westfälische Wilhelms-Universität Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Laurini+E%22">Laurini E</searchLink>; Molecular Biology and Nanotechnology Laboratory (MolBNL@UniTS), DEA, University of Trieste, Trieste, Italy.<br /><searchLink fieldCode="AU" term="%22Pricl+S%22">Pricl S</searchLink>; Molecular Biology and Nanotechnology Laboratory (MolBNL@UniTS), DEA, University of Trieste, Trieste, Italy.<br /><searchLink fieldCode="AU" term="%22Carbone+GM%22">Carbone GM</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wünsch+B%22">Wünsch B</searchLink>; Institut für Pharmazeutische und Medizinische Chemie, Westfälische Wilhelms-Universität Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Catapano+CV%22">Catapano CV</searchLink>; Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland. carlo.catapano@ior.usi.ch.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228711562%22">Oncogene</searchLink> [Oncogene] 2025 Nov; Vol. 44 (42), pp. 4032-4046. <i>Date of Electronic Publication: </i>2025 Sep 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8711562 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5594 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209509232%22">09509232 </searchLink><i>NLM ISO Abbreviation: </i>Oncogene <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40897798
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41388-025-03541-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4032
    Titles:
      – TitleFull: Integrated control of cancer stemness by σ1 receptor in advanced prostate cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Civenni G
      – PersonEntity:
          Name:
            NameFull: Sandrini G
      – PersonEntity:
          Name:
            NameFull: Merulla J
      – PersonEntity:
          Name:
            NameFull: Musumeci C
      – PersonEntity:
          Name:
            NameFull: Federici E
      – PersonEntity:
          Name:
            NameFull: Vallegra A
      – PersonEntity:
          Name:
            NameFull: Kokanovic A
      – PersonEntity:
          Name:
            NameFull: Mosole S
      – PersonEntity:
          Name:
            NameFull: Shinde D
      – PersonEntity:
          Name:
            NameFull: Sorrenti E
      – PersonEntity:
          Name:
            NameFull: Paganoni AJJ
      – PersonEntity:
          Name:
            NameFull: Marchetti M
      – PersonEntity:
          Name:
            NameFull: Valzelli R
      – PersonEntity:
          Name:
            NameFull: Albino D
      – PersonEntity:
          Name:
            NameFull: Pecoraro M
      – PersonEntity:
          Name:
            NameFull: Rinaldi A
      – PersonEntity:
          Name:
            NameFull: Bolis M
      – PersonEntity:
          Name:
            NameFull: Geiger R
      – PersonEntity:
          Name:
            NameFull: Winge T
      – PersonEntity:
          Name:
            NameFull: Holtschulte C
      – PersonEntity:
          Name:
            NameFull: Laurini E
      – PersonEntity:
          Name:
            NameFull: Pricl S
      – PersonEntity:
          Name:
            NameFull: Carbone GM
      – PersonEntity:
          Name:
            NameFull: Wünsch B
      – PersonEntity:
          Name:
            NameFull: Catapano CV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2025 Nov
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5594
          Numbering:
            – Type: volume
              Value: 44
            – Type: issue
              Value: 42
          Titles:
            – TitleFull: Oncogene
              Type: main
ResultId 1